how many americans take glp 1 Patrick Oben | in 9 now a GLP-1 medication. That's 11% of U.S. adults — up from just 3% in 2024. Nearly quadrupled in two years. But 4 in 10 Overweight Americans

Understanding the regulatory and prescribing landscape in the UK is critical for both patients and healthcare professionals considering either of these compounds

Based on SURMOUNT-1 data analysis, tirzepatide decreased the 10-year estimated risk of ASCVD for obese or overweight patients

brevis probiotic in women with HSV-2 genital herpes, probiotic use was similar to acyclovir with regard to improvement of symptoms and duration of healing

Achieve smooth, natural-looking results with a full syringe treatment

His practice is focused on complex reconstructive surgery as well as patient-focused aesthetic surgery

Review article: Role of glucagon-like peptide-1 receptor agonists in non-alcoholic steatohepatitis, obesity and diabetes-what hepatologists need to know